[Intravascular coagulation in paroxysmal nocturnal hemoglobinuria]

Autor: Ok, Gavrilov, Lagutina NIa, Fe, Faĭnshteĭn, Ai, Chizhova, Lyudmila Klimovich

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::edf78805c407c4f54e2ec67bd4a6598f
http://europepmc.org/abstract/med/6911850

One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study.

Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation. uralcytometry@gmail.com., Henze G; Department of Pediatric Oncology Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation.; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center Named After OK Gavrilov, Moscow, Russian Federation., Movchan L; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Stolyarova E; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Aleinikova O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (8), pp. 4629-4637. Date of Electronic Publication: 2022 Sep 28.

Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008.

Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. Electronic address: uralcytometry@gmail.com., Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.

Publikováno v: Leukemia research [Leuk Res] 2023 Feb; Vol. 125, pp. 106998. Date of Electronic Publication: 2022 Dec 16.

A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results.

Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. uralcytometry@gmail.com., Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation., Movchan L; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Stolyarova E; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Aleinikova O; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.

Publikováno v: Leukemia [Leukemia] 2022 May; Vol. 36 (5), pp. 1382-1385. Date of Electronic Publication: 2022 Mar 23.

[Achievements and prospects of clinical medicine].

Autor: Nesterov AP, Riabov GA, Gavrilov OK

Publikováno v: Vestnik Rossiiskoi akademii meditsinskikh nauk [Vestn Ross Akad Med Nauk] 1994 (11), pp. 6-12.